2025
Management of Severe Hypertriglyceridemia in Pregnancy With Niacin: Reevaluating Safety and Therapeutic Benefits
Suda N, Leon-Martinez D, Peter P, Flannery C, Irani R. Management of Severe Hypertriglyceridemia in Pregnancy With Niacin: Reevaluating Safety and Therapeutic Benefits. Case Reports In Endocrinology 2025, 2025: 2644678. PMID: 39949380, PMCID: PMC11824309, DOI: 10.1155/crie/2644678.Peer-Reviewed Original ResearchSevere hypertriglyceridemiaTG levelsAttention-deficient hyperactivity disorderManagement of severe hypertriglyceridemiaInsulin infusionSafety of niacinHistory of cholecystectomyIntravenous (IV) fluidsLow-fat dietPersonalized management approachPerceived side effectsCesarean sectionHypertriglyceridemic pancreatitisPrepregnancy BMIWeeks gestationPersistent hypertriglyceridemiaMaternal TGOmega-3 fatty acidsLong-term managementEarly deliveryPregnant womenAcute pancreatitisConventional therapyHypertriglyceridemiaInsulin regimens
2019
SAT-LB041 Insulin and IGF-2 Equally Regulate Placental Triglyceride Content
Anam A, Cooke K, O'Bryan J, Flannery C. SAT-LB041 Insulin and IGF-2 Equally Regulate Placental Triglyceride Content. Journal Of The Endocrine Society 2019, 3: sat-lb041. PMCID: PMC6552031, DOI: 10.1210/js.2019-sat-lb041.Peer-Reviewed Original ResearchPlacental lipid metabolismLean womenIGF-2Triglyceride contentLipid metabolismIGF-1Maternal triglyceride levelsMean age 34.4Elective C-sectionTime of presentationInsulin receptor isoformsMultiple comparison testColorimetric spectrophotometerNeonatal complicationsPlacenta explantsMaternal obesityNeonatal adiposityPlacental lipid contentMaternal insulinObese womenPregnant womenTG levelsTriglyceride levelsEndocrine SocietyVillous explants
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply